Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Tolvaptan ====== Tolvaptan (trade names Samsca, Jinarc, and others) is an aquaretic drug that functions as a selective, competitive [[vasopressin receptor 2]] (V2) [[antagonist]] used to treat [[hyponatremia]] associated with congestive [[heart failure]], [[cirrhosis]], and the [[Syndrome of inappropriate antidiuretic hormone secretion]] ([[SIADH]]). Tolvaptan was approved by the U.S. Food and Drug Administration (FDA) on May 19, 2009, and is sold by Otsuka Pharmaceutical Co. under the trade name Samsca. tolvaptan.txt Last modified: 2024/06/07 02:51by 127.0.0.1